Inflammatory myopathies: Issues in diagnosis and management
Authors:
Open Access
- 1 June 1997
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 10 (3) , 200-207
Abstract
Click on the article title to read more.Keywords
This publication has 37 references indexed in Scilit:
- Evaluation of muscle diseases using artificial neural network analysis of 31P MR spectroscopy dataMagnetic Resonance in Medicine, 1995
- Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Evaluation of muscles in a patient with suspected amyopathic dermatomyositis by magnetic resonance imaging and phosphorus-31-spectroscopyJournal of the American Academy of Dermatology, 1994
- The Treatment of Inclusion Body MyositisMedicine, 1993
- Plasma carnitine insufficiency and effectiveness of L‐carnitine therapy in patients with mitochondril myopathyMuscle & Nerve, 1993
- P‐31 Magnetic Resonance Spectroscopy in Polymyositis and DermatomyositisArthritis & Rheumatism, 1992
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- RACIAL VARIATION IN SERUM CREATINE KINASE UNRELATED TO LEAN BODY MASSRheumatology, 1990
- Creatine kinase activity inhibitor in sera from patients with muscle diseaseArthritis & Rheumatism, 1987
- Examination of a Case of Suspected McArdle's Syndrome by31P Nuclear Magnetic ResonanceNew England Journal of Medicine, 1981